Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terbutaline plus Danazol for Corticosteroid-Resistant or Relapsed ITP
NCT05494307Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of terbutaline in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
terbutaline
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05494307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494307.